References
- Al-Waili, K., Al-Zidi, W. A., Al-Abri, A. R., Al-Rasadi, K., Al-Sabti, H. A., Shah, K., Al-Futaisi, A., Al-Zakwani, I., Banerjee, Y. (2013). Mutation in the PCSK9 gene in Omani Arab subjects with autosomal dominant hypercholesterolemia and its effect on PCSK9 protein structure. Oman. Med. J., 28, 48–52.
- Anonymous (1999). Familial Hypercholesterolemia: Report of a Second WHO Consultation. WHO/HGN/FH/Cons/99.2, Geneva. 16 pp.
- Benn, M., Nordestgaard, B. G., Grande, P., Schnohr, P., Tybjaerg-Hansen, A. (2010). PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J. Amer. Coll. Cardiol., 55, 2833–2842.
- Benn, M., Watts, G. F., Tybjaerg-Hansen, A., Nordestgaard, B.G. (2012). Familial hypercholesterolemia in the danish general population: Prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab., 97, 3956–3964.
- Burns, F. (1920). A contribution to the study of the etiology of xanthomata. Arch. Derm. Syph., 2, 415–429.
- Calandra, S., Tarugi, P., Speedy, H. E., Dean, A. F., Bertolini, S., Shoulders, C. C. (2011). Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: Implications for classification and disease risk. J. Lipid. Res., 52, 1885–1926.
- Chatzistefanidis, D., Markoula, S., Vartholomatos, G., Milionis, H., Miltiadous, G., Georgiou, I., Elisaf, M., Kyritsis, A. (2013). First detection of hypercholesterolemia causing ApoB-100 R3527Q mutation in a family in Greece. Gen. Syndromes. Gene Ther., 4, 6.
- Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., Hobbs, H. H. (2004). Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science, 305, 869–872.
- Defesche, J. C., Lansberg, P. J., Umans-Eckenhausen, M. A., Kastelein, J. J. (2004). Advanced method for the identification of patients with inherited hypercholesterolemia. Semin. Vasc. Med., 4, 59–65.
- DeMott, K., Nherera, L., Shaw, E. J., Minhas, R., Humphries, S. E., Kathoria, M., Ritchie, G., Nunes, V., Davies, D., Lee, P., McDowell, I., Neil, A., Qureshi, N., Rowlands, P., Seed, M., Stracey, H., Thorogood, M., Watson, M. (2008). Clinical Guidelines and Evidence Review for Familial hypercholesterolaemia: The identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners.
- Eden, E. R., Patel, D. D., Sun, X. M., Burden, J. J., Themis, M., Edwards, M., Lee, P., Neuwirth, C., Naoumova, R. P., Soutar, A. K. (2002). Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1. J. Clin. Invest., 110, 1695–1702.
- Fasano, T., Cefalu, A. B., Di Leo, E., Noto, D., Pollaccia, D., Bocchi, L., Valenti, V., Bonardi, R., Guardamagna, O., Averna, M., Tarugi, P. (2007). A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. Arterioscler. Thromb. Vasc. Biol., 27, 677–681.
- Fisher, E., Scharnagl, H., Hoffmann, M. M., Kusterer, K., Wittmann, D., Wieland, H., Gross, W., Marz, W. (1999). Mutations in the apolipoprotein (apo) B-100 receptor-binding region: Detection of apo B-100 (Arg3500—Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405—Gln) diminishes receptor-mediated uptake of LDL. Clin. Chem., 45, 1026–1038.
- Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., Barnes, R., Cohen, J. C., Hobbs, H. H. (2001). Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science, 292, 1394–1398.
- Gaudreault, N., Ducharme, V., Lamontagne, M., Guauque-Olarte, S., Mathieu, P., Pibarot, P., Bosse, Y. (2011). Replication of genetic association studies in aortic stenosis in adults. Amer. J. Cardiol., 108, 1305–1310.
- Graham, C. A., McClean, E., Ward, A. J., Beattie, E. D., Martin, S., O'Kane, M., Young, I. S., Nicholls, D. P. (1999). Mutation screening and genotype: phenotype correlation in familial hypercholesterolaemia. Atherosclerosis, 147, 309–316.
- Graham, C. A., McIlhatton, B. P., Kirk, C. W., Beattie, E. D., Lyttle, K., Hart, P., Neely, R. D., Young, I. S., Nicholls, D. P. (2005). Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate. Atherosclerosis, 182, 331–340.
- Harada-Shiba, M., Takagi, A., Miyamoto, Y., Tsushima, M., Ikeda, Y., Yokoyama, S., Yamamoto, A. (2003). Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J. Clin. Endocrinol. Metab., 88, 2541–2547.
- Humphries, S., Whittall, R., Hubbart, C., Maplebeck, S., Cooper, J., Soutar, A., Naoumova, T., Thompson, G., Seed, M., Durrington, P., Miller, J. P., Betteridge, D. J., Neil, H. A. Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee (2006a). Genetic causes of familial hypercholesterolaemia in patients in the UK: Relation to plasma lipid levels and coronary heart disease risk. J. Med. Genet., 43, 943–949.
- Humphries, S. E., Whittall, R. A., Hubbart, C. S., Maplebeck, S., Cooper, J. A., Soutar, A. K., Naoumova, R., Thompson, G. R., Seed, M., Durrington, P. N., Miller, J. P., Betteridge, D. J., Neil, H. A.; Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. (2006b). Genetic causes of familial hypercholesterolaemia in patients in the UK: Relation to plasma lipid levels and coronary heart disease risk. J. Med. Genet., 43, 943–949.
- Ignatovica, V., Latkovskis, G., Peculis, R., Megnis, K., Schioth, H. B., Vaivade, I., Fridmanis, D., Pirags, V., Erglis, A., Klovins, J. (2011). Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population. Mol. Biol. Rep., 39, 1917–1925.
- Kotowski, I. K., Pertsemlidis, A., Luke, A., Cooper, R. S., Vega, G. L., Cohen, J. C., Hobbs, H. H. (2006). A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Amer. J. Hum. Genet., 78, 410–422.
- Lamsa, R., Helisalmi, S., Herukka, S. K., Tapiola, T., Pirttila, T., Vepsalainen, S., Hiltunen, M., Soininen, H. (2008). Genetic study evaluating LDLR polymorphisms and Alzheimer's disease. Neurobiol. Aging, 29, 848–855.
- Liao, Y. C., Lin, H. F., Rundek, T., Cheng, R., Hsi, E., Sacco, R. L., Juo, S. H. (2008). Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics. Clin. Biochem., 41, 306–312.
- Makela, K. M., Seppala, I., Hernesniemi, J. A., Lyytikainen, L. P., Oksala, N., Kleber, M. E., Scharnagl, H., Grammer, T. B., Baumert, J., Thorand, B., Jula, A., Hutri-Kähönen, N., Juonala, M., Laitinen, T., Laaksonen, R., Karhunen, P. J., Nikus, K. C., Nieminen, T., Laurikka, J., Kuukasjärvi, P., Tarkka, M., Viik, J., Klopp, N., Illig, T., Kettunen, J., Ahotupa, M., Viikari, J. S., Kähönen, M., Raitakari, O. T., Karakas, M., Koenig, W., Boehm, B. O., Winkelmann, B. R., März, W., Lehtimäki, T. (2012). Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium. Circ. Cardiovasc. Genet., 6, 73–81.
- Peculis, R., Latkovskis, G., Tarasova, L., Pirags, V., Erglis, A., Klovins, J. (2011). A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a Latvian population. DNA Cell Biol., 30, 907–911.
- Shioji, K., Mannami, T., Kokubo, Y., Inamoto, N., Takagi, S., Goto, Y., Nonogi, H., Iwai, N. (2004). Genetic variants in PCSK9 affect the cholesterol level in Japanese. J. Hum. Genet., 49, 109–114.
- Slack, J. (1969). Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet, 2, 1380–1382.
- Soria, L. F., Ludwig, E. H., Clarke, H. R., Vega, G. L., Grundy, S. M., McCarthy, B. J. (1989). Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. U.S.A., 86, 587–591.
- Taylor, A., Wang, D., Patel, K., Whittall, R., Wood, G., Farrer, M., Neely, R. D., Fairgrieve, S., Nair, D., Barbir, M., Jones, J. L., Egan, S., Everdale, R., Lolin, Y., Hughes, E., Cooper, J. A., Hadfield, S. G., Norbury, G., Humphries, S. E. (2010). Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin. Genet., 77, 572–580.